Discount Agreement for Mesalazine (excl. Dafo RSU + KLI)
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Mesalazin (ausschl. Dafo RSU + KLI), ATC A07EC02 für die Zeit 01.06.26 - 31.05.28 (zzgl. V.-Option 1x12 Mon)
Status
Active
Submission Deadline
913 days remaining
Contracting authority
Location
Hamburg, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-265020-2026
Source
DAK-Gesundheit offers pharmaceutical companies the opportunity to conclude framework agreements for the active ingredient Mesalazine. This applies to the dosage forms RSU + KLI and is planned for the period 01.06.26 - 31.05.28 with an extension option.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 265020-2026HTML
- TED PDF — 265020-2026PDF
- TED XML — 265020-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024